A sensitive and versatile bioassay for ligands that signal through receptor clustering

Journal of Interferon and Cytokine Research

Volumn 20, Issue 1, 2000, Pages 79-87

  Van Ostade, Xaveer ^a   Schauvliege, Liesbeth ^a   Pattyn, Els ^a   Verhee, Annick ^a   Vandekerckhove, Joël ^a   Tavernier, Jan ^a  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; ERYTHROPOIETIN; INTERFERON RECEPTOR; INTERLEUKIN 5; INTERLEUKIN 6; LEPTIN; PHOSPHORIBOSYLTRANSFERASE; TIOGUANINE; TUMOR NECROSIS FACTOR;

ARTICLE; BIOASSAY; CHIMERA; CYTOKINE RELEASE; CYTOTOXICITY; METHODOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

BIOLOGICAL ASSAY; COLORING AGENTS; CULTURE MEDIA; ENZYME INDUCTION; ERYTHROPOIETIN; FIBROSARCOMA; GENTIAN VIOLET; HUMANS; INTERFERON ALFA-2B; INTERFERON-BETA; INTERLEUKIN-5; INTERLEUKIN-6; LEPTIN; LIGANDS; MEMBRANE PROTEINS; NEOPLASM PROTEINS; PENTOSYLTRANSFERASES; RECEPTOR AGGREGATION; RECEPTOR, INTERFERON ALPHA-BETA; RECEPTORS, ERYTHROPOIETIN; RECEPTORS, INTERFERON; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-5; RECOMBINANT FUSION PROTEINS; SELECTION (GENETICS); SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; THIOGUANINE; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033959942     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/107999000312757     Document Type: Article

References (25)

1. MIRE-SLUIS, A.R., and THORPE, R. (1998). Laboratory protocols for the quantitation of cytokines by bioassay using cytokine responsive cell lines. J. Immunol. Methods 211, 199-210.
2. BIENVENU, J.A., MONNERET, G., GUTOWSKI, M.C., and FABIEN, N. (1998). Cytokine assays in human sera and tissues. Toxicology 129, 55-61.
3. MIRE-SLUIS, A.R., GAINES-DAS, R., and THORPE, R. (1995). Immunoassays for detecting cytokines: what are they really measuring? J. Immunol. Methods. 186, 157-160.
4. PELLEGRINI, S., JOHN, J., SHEARER, M., KERR, I.M., and STARK, G.R. (1989). Use of a selectable marker regulated by alpha interferon to obtain mutations in the signaling pathway. Mol. Cell. Biol. 9, 4605-4612.
5. VELAZQUEZ, L., FELLOUS, M., STARK, G.R., and PELLEGRINI, S. (1992). A protein tyrosine kinase in the interferon alpha/beta signaling pathway. Cell 70, 313-322.
6. DARNELL, J.E.J., KERR, I.M., and STARK, G.R. (1994). Jak-Stat pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264, 1415-1420.
7. UZE, G., LUTFALLA, G., and GRESSER, I. (1990). Genetic transfer of a functional human interferon alpha receptor into mouse cells: cloning and expression of its cDNA. Cell 60, 225-234.
8. DOMANSKI, P., WITTE, M., KELLUM, M., RUBINSTEIN, M., HACKETT, R., PITHA, P., and COLAMONICI, O.R. (1995). Cloning and expression of a long form of the beta subunit of the interferon alpha beta receptor that is required for signaling. J. Biol. Chem. 270, 21606-21611.
9. LUTFALLA, G., HOLLAND, S.J., CINATO, E., MONNERON, D., REBOUL, J., ROGERS, N.C., SMITH, J.M., STARK, G.R., GARDINER, K., and MOGENSEN, K.E. (1995). Mutant U5A cells are complemented by an interferon-alpha beta receptor subunit generated by alternative processing of a new member of a cytokine receptor gene cluster. EMBO J. 14, 5100-5108.
10. NOVICK, D., COHEN, B., and RUBINSTEIN, M. (1994). The human interferon alpha/beta receptor: characterization and molecular cloning. Cell 77, 391-400.
11. PELLEGRINI, S., and DUSANTER-FOURT, I. (1997). The structure, regulation and function of the Janus kinases (Jaks) and the signal transducers and activators of transcription (Stats). Eur. J. Biochem. 248, 615-633.
12. STARK, G.R., KERR, I.M., WILLIAMS, B.R., SILVERMAN, R.H., and SCHREIBER, R.D. (1998). How cells respond to interferons. Annu. Rev. Biochem. 67, 227-264.
13. TAVERNIER, J., DEVOS, R., CORNELIS, S., TUYPENS, T., VAN DER HEYDEN, J., FIERS, W., and PLAETINCK, G. (1991). A human high affinity interleukin-5 receptor (IL5R) is composed of an IL5-specific alpha chain and a beta chain shared with the receptor for GM-CSF. Cell 66, 1175-1184.
14. WATOWICH, S.S., YOSHIMURA, A., LONGMORE, G.D., HILTON, D.J., YOSHIMURA, Y., and LODISH, H.F. (1992). Homodimerization and constitutive activation of the erythropoietin receptor. Proc. Natl. Acad. Sci. USA 89, 2140-2144.
15. GUISEZ, Y., OEFNER, C., WINKLER, F.K., SCHLAEGER, E.J., ZULAUF, M., VAN DER HEYDEN, J., PLAETINCK, G., CORNELIS, S., TAVERNIER, J., and FIERS, W. (1993). Expression, purification and crystallisation of fully active, glycosylated human interleukin-5. FEBS Lett. 331, 49-52.
16. GRAHAM, F.L., and VAN DER EB, A.J. (1973). A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52, 456-467.
17. FAMILLETTI, P.C., Rubinstein, S., and Pestka, S. (1981). A convenient and rapid cytopathic effect inhibition assay for interferon. Methods Enzymol. 78, 387-394.
18. CANOSI, U., MASCIA, M., GAZZA, L., SERLUPI-CRESCENZI, O., DONINI, S., ANTONETTI, F., and GALLI, G. (1996). A highly precise reporter gene bioassay for type I interferon. J. Immunol. Methods 199, 69-76.
19. HAMMERLING, U., BONGCAM-RUDLOFF, E., SETTERBLAD, N., KROON, R., REHNSTRÖM, A.K., VIITANEN, E., ANDERSSON, G., and SJÖDIN, L. (1998). The β-Gal interferon assay: a new, precise, and sensitive method. J. Interferon Cytokine Res. 18, 451-460.
20. KOMATSU, N., YAMAMOTO, M., FUJITA, H., MIWA, A., HATAKE, K., ENDO, T., OKANO, H., KATSUBE, T., FUKUMAKI, Y., and SASSA, S. (1993). Establishment and characterization of an erythropoietin-dependent subline, UT-7/Epo, derived from human leukemia cell line, UT-7. Blood 82, 456-464.
21. KITAMURA, T., TANGE, T., TERASAWA, T., CHIBA, S., KUWAKI, T., MIYAGAWA, K., PIAO, Y.F., MIYAZONO, K., URABE, A., and TAKAKU, F. (1989). Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin. J. Cell. Physiol. 140, 323-334.
22. DAUBENER, W., WANAGAT, N., PILZ, K., SEGHROUCHNI, S., FISCHER, H.G., and HADDING, U. (1994). A new, simple, bioassay for human IFN-gamma. J. Immunol. Methods 168, 39-47.
23. MIRE-SLUIS, A.R., PAGE, L.A., MEAGER, A., IGAKI, J., LEE, J., LYONS, S., and THORPE, R. (1996). An anti-cytokine bioactivity assay for interferons-alpha, -beta and - omega. J. Immunol. Methods 195, 55-61.
24. VAN OSTADE, X., VAN DER HEYDEN, J., VERHEE, A., VANDEKERCKHOVE, J., and TAVERNIER, J. (1999). The cell surface expression level of the human interleukin-5 receptor α subunit determines the agonistic/antagonistic balance of the human interleukin-5 E13Q mutein. Eur. J. Biochem. 259, 954-960.
25. LAURICELLA-LEFEBVRE, M.A., CASTRONOVO, V., SATO, H., SEIKI, M., FRENCH, D.L., and MERVILLE, M.P. (1993). Stimulation of the 92-kD type IV collagenase promoter and enzyme expression in human melanoma cells. Invasion Metastasis 13, 289-300.